SCHEMBL14091183

SCHEMBL14091183

CC(=N)NCCCC(NC(=O)C(C)(C)C(=O)NC(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ C3AR1 Q16581 1/20 0.43
▸ FNTA P49354 1/20 0.39
▸ FNTB P49356 1/20 0.39
▸ PGGT1B P53609 1/20 0.39
▸ TGM2 P21980 2/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ MME P08473 2/20 0.38
▸ FOLH1 Q04609 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ MTNR1A P48039 1/20 0.37
▸ MTNR1B P49286 1/20 0.37
▸ MMP1 P03956 2/20 0.37
▸ MMP3 P08254 2/20 0.37
▸ MMP9 P14780 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14090782 0.90 C3AR1 (0.47) C3AR1FNTAFNTBPGGT1BCNR1
SCHEMBL4565586 0.90 C3AR1 (0.47) C3AR1FNTAFNTBPGGT1BCNR1
SCHEMBL14090878 0.88 NPSR1 (0.50) MEN1KMT2AALDH1A1NPSR1MMP1
SCHEMBL1983969 0.77 FOLH1 (0.47) C3AR1FOLH1
SCHEMBL12560085 0.77 FOLH1 (0.47) C3AR1FOLH1
SCHEMBL4992532 0.76 C3AR1 (0.60) C3AR1FOLH1
SCHEMBL14646356 0.75 LMNA (0.51) CNR1CNR2MEN1KMT2AALDH1A1
SCHEMBL4994969 0.73 C3AR1 (0.49) C3AR1
SCHEMBL4995868 0.73 C3AR1 (0.66) C3AR1
SCHEMBL4436517 0.73 C3AR1 (0.63) C3AR1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof ENCYSIVE PHARMACEUTICALS, INC. 2008-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188528-A1 Modulators of C3a receptor and methods of use thereof C3AR1, C5, C5AR1 C3AR1 1/4885FNTA 863/4885FNTB 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback